tiprankstipranks

Melissa B Epperly Insider Profile

4 Followers
Melissa B Epperly, CFO at Zentalis Pharmaceuticals, holds 451.45K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds ― shares in Kinnate Biopharma (Ticker: KNTE), holds ― shares in Nautilus Biotechnolgy (Ticker: NAUT).
tipranks
Melissa B Epperly

Melissa B Epperly
Zentalis Pharmaceuticals (ZNTL)
CFO

Ranked #44,965 out of 98,743 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+7.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
95.29%
4.71%
0.00%
A breakdown of Melissa B Epperly's holdings

Insider Roles

Zentalis Pharmaceuticals
(ZNTL)
CFO
Roivant Sciences
(ROIV)
Director
Nautilus Biotechnolgy
(NAUT)
Director
Roles that Melissa B Epperly holds in companies

Most Profitable Insider Trade

Stock:
Zentalis Pharmaceuticals
(ZNTL)
Rating:Informative Buy
Date:Nov 25, 2020 - Nov 25, 2021
Return:+68.30%
The most profitable trade made by Melissa B Epperly

Melissa B Epperly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Zentalis Pharmaceuticals
Feb 12, 2024
CFO
Uninformative Sell
29.44K
$5.29M
KNTE
Kinnate Biopharma
Nautilus Biotechnolgy
Director
Roivant Sciences
Apr 26, 2024
Director
Uninformative Buy
$261.71K
List of latest transactions for each holding click on a transaction to see Melissa B Epperly's performance on stock

Melissa B Epperly insider profile FAQ

What is the percentage of profitable transactions made by Melissa B Epperly?
The percentage of profitable transactions made by Melissa B Epperly is 50%.
    What is the average return per transaction made by Melissa B Epperly?
    The average return per transaction made by Melissa B Epperly is 7.90%.
      What stocks does Melissa B Epperly hold?
      Melissa B Epperly holds: ZNTL, KNTE, NAUT, ROIV stocks.
        What was Melissa B Epperly’s latest transaction?
        Melissa B Epperly latest transaction was an Uninformative Sell of $29.44K.
          What was Melissa B Epperly's most profitable transaction?
          Melissa B Epperly’s most profitable transaction was an Informative Buy of ZNTL stock on November 25, 2020. The return on the trade was 68.30%.
            What is Melissa B Epperly's role in Zentalis Pharmaceuticals?
            Melissa B Epperly's role in Zentalis Pharmaceuticals is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.